Suchergebnisse - "Aghemo, Alessio"

PubPharm (54)

1

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2020

von Soria, A. | Fava, M. | Bernasconi, D. | +60

2

Do gamma-glutamyltransferase levels identify HCV patients who require lifelong post-SVR follow-up?

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2020

von Colapietro, F. | Aghemo, A.

CommentOn: Liver Int. 2020 Mar;40(3):539-548. - PMID 31241820

3

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

enthalten in: Infection | 2018

von Ascione, A. | De Luca, M. | Melazzini, M. | +118

4

Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy : The STIly observational study

enthalten in: Medicine | 2018

von Gaeta, G. | Aghemo, A. | Menzaghi, B. | +7

5

12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Degasperi, E. | Aghemo, A. | Paolucci, S. | +8

6

Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease : A long-term follow-up

enthalten in: The International journal of artificial organs | 2018

von Fabrizi, F. | Aghemo, A. | Lampertico, P. | +6

7

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2017

von Bruno, S. | Di Marco, V. | Iavarone, M. | +11

8

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS) : a prospective observational study

enthalten in: The lancet. Gastroenterology & hepatology | 2017

von Petta, S. | Marzioni, M. | Russo, P. | +123

ErratumIn: Lancet Gastroenterol Hepatol. 2017 Jun;2(6):e3. - PMID 28497762

9

Direct-acting antivirals : the endgame for hepatitis C?

enthalten in: Current opinion in virology | 2017

von D'Ambrosio, R. | Degasperi, E. | Colombo, M. | +1

10

Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant : case series and review of the literature

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von D'Ambrosio, R. | Aghemo, A. | Rossetti, V. | +2

1
2
3
4
5
6
Nächster »
[6]